352 Final Results of the First in Man Trial of MK4827, a Poly (ADP-ribose) Polymerase (PARP) Inhibitor with Antitumor Activity in BRCA Carriers and Sporadic Cancer Patients
作者
Shahneen Sandhu,G. Wilding,William R. Schelman,Aurelius Omlin,N. Kreischer,Catherine L. Carpenter,Raffaele Iannone,Stuart Kaye,J.S. de-Bono,R.M. Wenham